Choose your starting point
What are you trying to do?
Start with the problem in front of you. The curriculum connects the concepts as you go.
Put AI to work
Set up an assistant that knows your context, finish a real task with it, and judge whether a model deserves your trust.
02 · LEARNRead clinical evidence
Study design, effect sizes, regression, survival analysis, and power. No statistics degree required.
03 · APPLYSolve today’s problem
Scan a paper, pick the right test, prep journal club, or set up a daily literature briefing.
Clinical Evidence and Statistics
Start here: 6 available modules from paper reading to power
Reading a Paper Without Faking It
Study design, hierarchy of evidence, and spotting red flags before you get fooled.
Choosing the Right Test
Variable types, study design, and the decision tree for test selection.
Understanding Your Output
P-values, confidence intervals, effect sizes, and how to smell a fragile result.
Survival Analysis for Surgeons
Kaplan-Meier, Cox regression, competing risks, and why your amputation data needs special handling.
Regression Without Crying
Linear, logistic, ordinal. When to use each, how to interpret coefficients, and why your 15-variable model is garbage.
Sample Size and Power
Why your retrospective study is underpowered, how to calculate what you need, and when to admit defeat. Includes an interactive power calculator.
Journal Club
Landmark trials, dissected
How to read a prediction model
A guideline-endorsed lifetime risk model for established vascular disease — and a working tour of discrimination vs calibration, competing risks, and turning a trial's average effect into one patient's life-years gained. Eur Heart J, June 2026.
When 5-year ≠ 10-year
PCI vs CABG for unprotected left main disease. The composite said PCI lost. A decade later, the mortality curves are superimposable. A masterclass in why follow-up duration changes the story.
Stenting wins, CEA... doesn't?
Stenting beat medical therapy. CEA didn't reach significance. The trial that's reshaping how we think about asymptomatic carotid disease.
One program, two trials, same answer
3,500 patients across two parallel Swedish trials. No amputation benefit in CLTI, no QoL benefit in claudication, and a 5-year mortality signal. The case against routine paclitaxel-coated devices.
Aspirin + anticoagulation: friend or foe?
Chronic coronary syndrome patients on oral anticoagulation. When standard of care is scary.
Tools
Quick utilities for the paper, the analysis, or the journal club in front of you
Is This Paper Worth My Time?
Answer 7 quick questions about a study to get a read/skim/skip verdict with specific red flags and strengths.
Scan a paperWhich Test Do I Need?
Walk through your study design step-by-step to get the right statistical test, assumptions to check, and what to report.
Find your testPrep Your Journal Club
Walk through a 10-step framework and leave with a presentation ready to deliver in under 10 minutes.
Start preppingBuild Your Morning Briefing
A free setup prompt for Claude that builds a daily PubMed digest curated to your specialty, deduped against papers you've already read.
Set it up